Gérard Lledo

Medicine · Health Sciences

32h-index9.4kcitations225works0.32yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(98), Gastric Cancer Management and Outcomes(58), Cancer Treatment and Pharmacology(51), Pancreatic and Hepatic Oncology Research(30), Colorectal and Anal Carcinomas(26)

Publications223 total

Decreasing prevalence and cumulative incidence of scleroderma renal crisis over time: associated factors identified from the RESCLE registry
Lara D. Veeken·2025· 1 cited
Persistence of dysfunctional immune response 12 months after SARS-CoV-2 infection and their relationship with pulmonary sequelae and long covid
2024Open Access
Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer
The Oncologist·2024Open Access
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
Journal of Clinical Oncology·2023· 188 cited
Persistence of specific T-cell response in patients with Long COVID and pulmonary sequelae
03.02 - Airway cell biology and immunopathology·2023· 1 cited
Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904)
Radiotherapy and Oncology·2019· 13 cited
Prise en charge thérapeutique des cancers colorectaux métastatiques au-delà de la deuxième ligne
2019
Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study
Cancer Management and Research·2018· 11 citedOpen Access
Cancer colorectal métastatique : place du traitement d’entretien et de la pause thérapeutique
Bulletin du Cancer·2018· 3 cited
Impact of primary tumor sidedness on erlotinib efficacy in patients with metastatic colorectal cancer treated with bevacizumab maintenance: Results from the DREAM phase III trial.
Journal of Clinical Oncology·2018· 2 cited
Cáncer de esófago
EMC - Tratado de Medicina·2017
Cancer de l'œsophage
2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
Annals of Oncology·2017· 105 citedOpen Access
PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers
Radiotherapy and Oncology·2017
Role of tritherapy with fluorouracil/leucovorin, irinotécan and oxaliplatin in the treatment of metastatic colorectal cancer
2017
Care pathway of patients with metastatic pancreatic cancer in daily practice in France: Results from the REPERE national survey
Bulletin du Cancer·2017· 5 cited
Cancers non métastatiques de l’œsophage : quelle prise en charge pratique en 2016 ?
2016
P-156 Pathologic response of liver metastases from colorectal cancer after chemotherapy and aflibercept: initial report of 23 cases from 9 patients
Annals of Oncology·2016· 1 citedOpen Access
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX
European Journal of Cancer·2016· 16 cited
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
The Lancet Oncology·2015· 120 cited
page 1 of 12Next →

Frequent Co-authors

Thierry André(28), Aimery de Gramont(19), Christophe Louvet(18), Christophe Tournigand(14), Laurent Mineur(14), M. Flesch(13), Benoist Chibaudel(12), Olivier Dupuis(11), Armand de Gramont(11), Arié Figer(9), Pascal Artru(9), Michel Ducreux(8), Élisabeth Carola(8), May Mabro(8), Andrés Cervantes(7), Pierre-Luc Etienne(6), Olivier Bouché(6), Franck Bonnetain(6), Emmanuel Quinaux(5), Marc Buyse(5)